Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:c004:0:b0:1eb:e128:bbe3 with SMTP id l4csp1272847eic;
        Wed, 10 Jan 2024 17:44:17 -0800 (PST)
X-Google-Smtp-Source: AGHT+IEq04p8Wmnz99EFV4bDO7ge8Hb+8RjESyZ3fN9eJ/6HOcY7eJxRv/ob6LKa5q3ybq1xlwFS
X-Received: by 2002:ac8:5f95:0:b0:429:9341:ddf2 with SMTP id j21-20020ac85f95000000b004299341ddf2mr1946qta.29.1704937456649;
        Wed, 10 Jan 2024 17:44:16 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1704937456; cv=none;
        d=google.com; s=arc-20160816;
        b=wJzZvDF3wJoyp+7NOhGM+oYhHU87Uov6gsmWRY4j9wUznpkusfDt0+b+YcsoJCvZcl
         Q21tFVaPI5nqEs+t62olwhsCirDQ4rKuKZ6pmg9ievGayatZmrLrrPMxh67mYhpiZMkk
         OrmxCIBqrxFKEsY8OTyPJMumMwzlkvsv1SQcOkza6v2loj8WBg0NkV+Ohrpl6JGWUObP
         yOje8exD1syHqL9fLBpMmqxegQDDkdAQ8Y1OEqFmaGRb7Rnh+Ka1A9A0w+6yVn9MdtOF
         kUQanxbhMeZ8YojsHW5UMHkuUisrGugJVqntBEXkwWZDB1nMvlWTCmq5sWO3WTXk52xa
         Uumw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=jRViCtIWZ2NB392mrsS/F3S17FwFYJgmdie0EShkOAc=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=Kcy1Lyfn/g2Mklx3TCviLHlhdCOeXBv9x5c38sJIdiRb/mR98uxCIm8B62q1dy6MLz
         HGyE4I/oPa80NgxPxhQIl+wR84cpRLu9JOJ9foQTMvPC4YKVfEHa3MHegMaV+vrWdXem
         6ZaACGWXoxmzXgO/RQxfhmia2qQbg9EBjHvCbBogctqH8WA5vNwAKPlV7GH+fAmBctRK
         N7nMCJT/5Nwtle48eVF/nMop5QJCcVnov6ahmYJAvj9UoMsvXo05Y2HkMvlmrh1CPTzj
         6GfDKXzZ1wgHrQT+7wd6KgJhU+8BCpr9/1YyOfkuKa0qN/WIFIreC6GQCXKTuAp6wgRT
         F1XA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=X68f3gVg;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=gWw+nuvk;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id u4-20020a05622a198400b00429bcc07136si78607qtc.71.2024.01.10.17.44.16
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Wed, 10 Jan 2024 17:44:16 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=X68f3gVg;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=gWw+nuvk;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=jRViCtIWZ2NB392mrsS/F3S17FwFYJgmdie0EShkOAc=;
	b=X68f3gVgUqaevtIowcN3aGEshvn88lYAaZfT1Y8tlN5Wdtj0d05zXoDlFTLt7of7Om3i
	28Pz6rPYxR+G4yx5CZy681XbKFUw1nofl1cwJ5GcwNclbrgO6GNGRetfqihXv34qJV2nm1
	6Hv3Ngg8CLvGHjDzoA+JdxJeq5UUAPHwtpltNQmqf9tM/u8nDEFObxdax4PLem8LLszy/O
	UBUzbcYVmYfQ5w8XGcGzLpGCCCOHSpj5gwRAj4tTBiKHtJxn8byG/Pv0dmdNHkv3BrU6cR
	QdTC72fmZhDFhuiihleFiI+HrinNddNmoeNR3JsDCl5LVrkplOH4WSAsGuuCkrQg==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=jRViCtIWZ2NB392mrsS/F3S17FwFYJgmdie0EShkOAc=;
	b=gWw+nuvkJCeqcCFX5tCX9Uau1j4lUe8u5B4I2/Z3oath8NDtsMGq0CeOSS3vqAPr7Fek
	4KYQPiT3s+69Rca9Rtcm0VX5U2khhPbE6eyWOJr2RdVu79ZrpfwP4OrHOlnR0hHRfnAF5B
	r+p+TwAWlW18rQhDZ6KR4E7EVEES5fS8U=
Received: by filterdrecv-b7c5b88-jpbhf with SMTP id filterdrecv-b7c5b88-jpbhf-1-659F47EE-23
        2024-01-11 01:44:14.375051616 +0000 UTC m=+7369335.881558973
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-25 (SG) with HTTP
	id QpJqyow-RR2On1eKBDFr-A
	Thu, 11 Jan 2024 01:44:14.340 +0000 (UTC)
Content-Type: multipart/alternative; boundary=04f14b2b4a8967261790b91bbeae5873911717062fdc21b176e90291299e
Date: Thu, 11 Jan 2024 01:44:16 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <QpJqyow-RR2On1eKBDFr-A@geopod-ismtpd-25>
Subject: PRO/AH/EDR> COVID-19 update (05): Pakistan, JN.1, variant of interest
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBKjWxSzWGMJ9f6ni69c7IhrpsDiUwR2hU1kav+?=
 =?us-ascii?Q?sbeXXELh3EpmsXl7TzEVRCkcLpRBfl9ihRFvjHJ?=
 =?us-ascii?Q?wx21A5gJntUg9zajf4Zz=2FPtnqkAwtsXfm84HtJh?=
 =?us-ascii?Q?SC8TKQpuWbHw3Bd4RKfyD=2FA+av6lcp3joN0e765?=
 =?us-ascii?Q?8w1y9YpVvi28P4vYMJCqpxEjFKT9iXJzwh4J5x?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUiShGf=2FO8XJWpH34Od4Nd?=
 =?us-ascii?Q?fxXa6jil96uRcJkF+N+LeVnO1tx80ddOyoyOo=2Fc?=
 =?us-ascii?Q?Brxcl3ERAm0cOY743=2FFH59DWiSf5OzXORh1DLKt?=
 =?us-ascii?Q?hb1NMKty3PsA5ju0ZzxCrq1WQuZSEQf=2FJlWtgqv?=
 =?us-ascii?Q?cZmsyCHlNUZsDXYELw3NABlnYHcvCZCAmdKRbNH?=
 =?us-ascii?Q?DZbd4VYaxeU2NkLgI+1GedeNNw6Yj3y6hKRpNUO?=
 =?us-ascii?Q?l9zlfgaiAQ+t266US57H9yXrvjeCEvJsXUsDHCd?=
 =?us-ascii?Q?S9EUluA8lqvBQFpaeBS3dHKgpPKxf5182ZHFPeW?=
 =?us-ascii?Q?pyUUjc+mGpIVW5ZYM0eXMKRP4lxz4mJBx=2F21jY=2F?=
 =?us-ascii?Q?mIk6ZVAGz5LDI4z6YvaQ8buCINxXdnGoONlzsZM?=
 =?us-ascii?Q?nJZdAWxp=2FK1cvRyQVy8C9CZ2h=2Fv6p1vNN1KJznl?=
 =?us-ascii?Q?KAqaR3kjus9xKVue+LkKtdaySLonh0Rfaq0TdRk?=
 =?us-ascii?Q?4eJXhmWUsoiceUsoRuUbyoS9n6Ptz6MicH=2FbMID?=
 =?us-ascii?Q?pvJ=2Fn8Uu6KwiOIyyeQNs0Z=2FEj=2F1M3CFNfqQ2KQD?=
 =?us-ascii?Q?qNUibpVlZHNX40T9gBrwyAHgAwAzB+7qBy+rgms?=
 =?us-ascii?Q?NzxqxzpAEpf=2FaivNq7Vj34TyJC1A+EPlkBJJLkH?=
 =?us-ascii?Q?km4j8wd4z+gZJlc8qQIOL54D70JCWYEOVPh+A9Q?=
 =?us-ascii?Q?I+WecFHQtkEGFJocgNSwDnMZwPmigZ0vWKPdQ64?=
 =?us-ascii?Q?axE7kOzZ7IjAmWiJDmjAF4bs41hY4Y8fZLgbpaJ?=
 =?us-ascii?Q?dKMZr=2F1SVxSH9dWZIE=2FNRZE5=2Fg=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2EeBl5kKr2d?=
 =?us-ascii?Q?UKw55t2=5F9aKrx-DGNmAv8d8tpdezDLJvjZoMDAw?=
 =?us-ascii?Q?dTAwMOCmM1rKj3C06Wv04VhGu4kQHzSZvpvCSoc?=
 =?us-ascii?Q?Izuke=5FsU1eQ8yxxW0TJEzGRTc=5FLAGJGf3exPLeT?=
 =?us-ascii?Q?zPTmEDOvcicRERNQQwGhv=5FiDQmYCWZyV27gWakg?=
 =?us-ascii?Q?Qi0hP=5FQ3G-uz-RUjw=3D=3D=2EFyTzoZkmYzv4KMZm9fh?=
 =?us-ascii?Q?CsQ92ooIZvl-l3OXkRT1D-yJoMDAwdTAwMOpMti?=
 =?us-ascii?Q?ZP0UWHUcvENEQcWX7VJUqwcfulxtUrXDg58NpPg?=
 =?us-ascii?Q?pwjCSmFZalP1I0cbPIfdCQRrQueERVUnMTrL1wb?=
 =?us-ascii?Q?b92MaHyzaL8j0nzMwtdzQbjyHcfH3Nhi-74CCUc?=
 =?us-ascii?Q?SnXV12DF1D6-MuC3SdAs4p2SGMbKPve2Ix3mHxe?=
 =?us-ascii?Q?7uYgQv52L14aq0qwG6aN7izqeyPXmHGNZM6exeQ?=
 =?us-ascii?Q?ENXsj=5FBCTvtL63WI2GdIl1mdTaC0Vu5yv4b=5FSCT?=
 =?us-ascii?Q?PeYMoPWSQbnX98FzUslyx76sEn72StzPu-zPN12?=
 =?us-ascii?Q?zKObIKd0U=5FGQm7Dh92rXOhVN172DSejIoYdRFNw?=
 =?us-ascii?Q?1x6k2Wrw-wI1-fmW379PfVE38xzjKii4dQMwQY4?=
 =?us-ascii?Q?bi0wOPS9LwUckmBnoqMQ4h=5FvJAsuPINRrGa0=5Fzn?=
 =?us-ascii?Q?wmYstpCNOyQoEHAxggLYFR=5FkH1GEzAbhWpIf1iK?=
 =?us-ascii?Q?Yo9iZc11VP5xFlKjGSn=5FGYHm11sY6SaS1bIdjc=5F?=
 =?us-ascii?Q?v2Jt4dDwDhdJ79Gt3TOrDVrL4nWv4zNTvhGdhlT?=
 =?us-ascii?Q?9tPGYfzPm2BtKOVWVmR-EEe05ybVmy8-HQ-7EXq?=
 =?us-ascii?Q?nyBwa=5FT-QBeSpyaf9ho8S3dIUwl-s1nD0lH=5FPog?=
 =?us-ascii?Q?KL0J6qKKABeAGAPcMhe-lZ-o7RjfQZIo6clKf2p?=
 =?us-ascii?Q?URnFsec-kGcBSf6D3VBQqqJBbHC=5F2eQPRlmW6Vz?=
 =?us-ascii?Q?7L40DkfbBqTIA8GtuPIs1f5-2KZCI6cpBSQStQF?=
 =?us-ascii?Q?-eQX=5F0F0U7aLzkPKnLGdLGf8jTg3RGiIAGe0tui?=
 =?us-ascii?Q?n5A0f3wLa=5FKuyrJbSdX-OCyaGGlDeneZlDoXQdu?=
 =?us-ascii?Q?SF7Zhr24FYgsegHDtO2VY55PfR6Jn2109Ohmepp?=
 =?us-ascii?Q?dVlHOSeQX5xdF9-muGHYLwrSuPO5Ocs94DVoWUy?=
 =?us-ascii?Q?9BKweiiLJ1XY4nM=5FB2eAAXsojYxvkTMw-ILY-28?=
 =?us-ascii?Q?lnV4frGQI1QZSWFokBcAK5L=5FRFjO1zSlCRrhNLj?=
 =?us-ascii?Q?fYIA-Nad=5FarFR-w-thtD66dxi8jJlYJ5KoV0yjj?=
 =?us-ascii?Q?EJlp152rnb-AC9z98Kmn9NfFU-7C2e0kBHdYlmn?=
 =?us-ascii?Q?OY9ZaA=3D=3D=3E?=

--04f14b2b4a8967261790b91bbeae5873911717062fdc21b176e90291299e
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

CORONAVIRUS DISEASE 2019 UPDATE (05): PAKISTAN, JN.1, VARIANT OF
INTEREST
*************************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Mon 8 Jan 2023 08:05 PKT
Source: The Nation [edited]
<https://www.nation.com.pk/08-Jan-2024/four-cases-of-jn1-virus-detected-in-=
pakistan>


The Ministry of Health's spokesperson has confirmed that 4 cases of
the JN.1 variant, an omicron sub-variant of the new coronavirus, have
been identified in Pakistan. According to the spokesperson, all
affected individuals exhibited mild symptoms, and they have since
recovered without complications.

The spokesperson added that the World Health Organization (WHO) has
designated JN.1 as a variant of interest. Caretaker Federal Minister
for Health Dr Nadeem Jan emphasized that the government is actively
monitoring the situation. Border health services and national and
provincial health authorities' labs are on high alert, operating under
the health minister's directives to closely track the disease's
developments.

--
Communicated by:
ProMED
via
ProMED-SoAs

[As indicated in the news report above, the presence of JN.1
sub-variant has been detected in 4 COVID-19 cases in Pakistan. With
this report, Pakistan has become the 2nd country in South Asia after
India reporting the circulation of this more infectious sub-variant.
It would not be surprising to see a temporal increase of COVID-19
cases in the country due to spread of this sub-variant because of
noticing an increasing trend of COVID-19 cases in India suspected to
be associated with the circulation of it (see archive nos.
http://promedmail.org/post/20240103.8714031,
http://promedmail.org/post/20231226.8713894 at
<https://promedmail.org/?lang=3Dsoas>).

Of note, "JN.1 is closely related to the variant BA.2.86.... It is not
currently known whether JN.1 infection produces different symptoms
from other variants. In general, symptoms of COVID-19 tend to be
similar across variants. The types of symptoms and how severe they are
usually depend more on a person's immunity and overall health rather
than which variant causes the infection." - Mod.PKB
(<https://www.cdc.gov/respiratory-viruses/whats-new/SARS-CoV-2-variant-JN.1=
.html>)

ProMED map of Pakistan:
<https://promedmail.org/promed-post?place=3D8714143,140>]

[See Also:
COVID-19 update (03): Israel, JN.1, new variant
http://promedmail.org/post/20240104.8714055
COVID-19 update (02): India
http://promedmail.org/post/20240103.8714052
COVID-19 update (01): Cambodia, new JN.1 variant detection
http://promedmail.org/post/20240101.8714020
2023
----
COVID-19 update (39): Saudi Arabia, JN.1 variant, MOH
http://promedmail.org/post/20231222.8713858
COVID-19 update (38): WHO classifies JN.1 coronavirus strain as
'variant of interest' http://promedmail.org/post/20231220.8713808
COVID-19 update (37): vaccine comp., selected regions, circ. variants,
research http://promedmail.org/post/20231219.8713789
COVID-19 update (36): selected countries/regions, vaccines
http://promedmail.org/post/20231212.8713666
COVID-19 update (35): Singapore, increase
http://promedmail.org/post/20231209.8713618
COVID-19 update (34): selected country/region updates, variants, WHO
http://promedmail.org/post/20231130.8713398
COVID-19 update (33): country updates, vaccines, vaccine refusal, WHO
update http://promedmail.org/post/20231105.8713000
COVID-19 update (32): updates, variants, vaccines, antivirals,
scientific literature http://promedmail.org/post/20231026.8712809
COVID-19 update (31): BA.2.86 & EG.5, selected regions, vaccines, WHO,
global http://promedmail.org/post/20231009.8712522
COVID-19 update (30): omicron EG.5.1, updates, WHO, global
http://promedmail.org/post/20230815.8711701
COVID-19 update (29): updates, wastewater surveillance, transmission,
WHO, global http://promedmail.org/post/20230802.8711526
COVID-19 update (28): superspread, masks, vaccination, WHO, global
http://promedmail.org/post/20230724.8711339
COVID-19 update (27): vaccination, test kit distribution, sequelae,
WHO, global http://promedmail.org/post/20230717.8711208
COVID-19 update (26): animal, North America, wild deer as reservoirs
http://promedmail.org/post/20230713.8711124
COVID-19 update (25): vaccines, liver disease, sequelae, WHO, global
http://promedmail.org/post/20230713.8711095
COVID-19 update (24): long-term effects, EU.1.1, wild bat, WHO, global
http://promedmail.org/post/20230704.8710946
COVID-19 update (23): EU transition plan, viral emission, vacc
hesitancy, GBS, WHO http://promedmail.org/post/20230619.8710662
COVID-19 update (22): trends, immunity, children, metformin, WHO
http://promedmail.org/post/20230612.8710546
COVID-19 update (21): countries, life expectancy, long COVID,
research, WHO, global http://promedmail.org/post/20230605.8710423
COVID-19 update (20): countries, Paxlovid, vaccine, WHO
http://promedmail.org/post/20230530.8710317
COVID-19 update (19): countries, vaccine composition, XBB1.16, WHO,
global http://promedmail.org/post/20230522.8710178
COVID-19 update (18): country/regional, vaccine policies, vaccination,
WHO, global http://promedmail.org/post/20230516.8710088
COVID-19 update (17): WHO, USA, India, China, XBB.1.16, research,
global http://promedmail.org/post/20230508.8709926
COVID-19 update (16): XBB.1.16, reinfections, microglia, sequelae,
WHO, global http://promedmail.org/post/20230502.8709789
COVID-19 update (15): India, XBB.1.16, fetal brain damage, HCW, global
http://promedmail.org/post/20230417.8709526
COVID-19 update (14): countries, vaccines, XBB.1.16, long COVID, WHO
http://promedmail.org/post/20230407.8709377
COVID-19 update (13): India, surveillance, HCW, rats, infant
hospitalizations, WHO, global
http://promedmail.org/post/20230329.8709196
COVID-19 update (12): countries, variants, susceptibility, vaccines,
WHO, global http://promedmail.org/post/20230321.8709066
COVID-19 update (11): country responses, complications, treatment,
WHO, global http://promedmail.org/post/20230312.8708900
COVID-19 update (10): Hong Kong, XBB.1.5, Iran, UAE, bivalent vacc
http://promedmail.org/post/20230308.8708776
COVID-19 update (09): XBB.1.5, vaccine, WHO
http://promedmail.org/post/20230228.8708641
COVID-19 update (08): countries, immunity, vaccines, treatment, masks,
WHO, global http://promedmail.org/post/20230219.8708482
COVID-19 update (07): countries, molnupiravir, vaccines, PACS,
cockroach, WHO http://promedmail.org/post/20230212.8708331
COVID-19 update (06): China, demographics, symptoms, PACS, WHO
http://promedmail.org/post/20230204.8708165
COVID-19 update (05): PHEIC continues, WHO
http://promedmail.org/post/20230130.8708059
COVID-19 update (04): PHEIC, China, susp outbreaks, responses,
vaccines, global http://promedmail.org/post/20230130.8708043
COVID-19 update (03): China, guidelines, vacc, immunity, sequelae, WHO
http://promedmail.org/post/20230122.8707910
COVID-19 update (02): China, XBB.1.5, Hong Kong, mAb, pathogenesis,
WHO, global http://promedmail.org/post/20230115.8707786
COVID-19 update (01): China, Hong Kong, XBB.1.5, PAHO, treatment,
testing, WHO http://promedmail.org/post/20230107.8707667
2022
----
COVID-19 update (193): surge, travel restrictions, screening,
treatment, WHO http://promedmail.org/post/20221230.8707528
COVID-19 update (191): omicron BF.7, bivalent vaccines, China, WHO,
global http://promedmail.org/post/20221224.8707437
COVID-19 update (190): China, Australia, vaccines, sequelae, WHO,
global http://promedmail.org/post/20221219.8707306
COVID-19 update (189): mortality, mAb, intranasal vacc, NPIs,
sequelae, WHO, global http://promedmail.org/post/20221209.8707146
COVID-19 update (188): China, omicron BA.2.76, outdoor transmission
http://promedmail.org/post/20221130.8706983
COVID-19 update (187): boosters, omicron BQ.1.1, Asia, Australia, WHO,
global http://promedmail.org/post/20221129.8706920
COVID-19 update (185): chr. COVID, bladder, recovery, renal, deaths,
WHO, global http://promedmail.org/post/20221111.8706665
COVID-19 update (184): vaccination response, disparity, WHO, global
http://promedmail.org/post/20221104.8706549
COVID-19 update (183): cardiac events, exercise, US deaths, boosters,
WHO, global http://promedmail.org/post/20221028.8706414
COVID-19 update (182): frontline workers, life expectancy,
subvariants, WHO, global http://promedmail.org/post/20221021.8706286
COVID-19 update (181): Africa vacc hesitancy, pre-eclampsia, boosters,
nasal vacc, WHO, global http://promedmail.org/post/20221014.8706143
COVID-19 update (180): long COVID, neuropsy. illness, Paxlovid,
subvariants, WHO http://promedmail.org/post/20221007.8706007
COVID-19 update (170): case severity, boosters, physical activity,
WHO, global http://promedmail.org/post/20220825.8705236
COVID-19 update (160): vaccine rollout disparities, smell & taste,
WHO, global http://promedmail.org/post/20220731.8704776
COVID-19 update (150): France, omicron 2nd gen variant, paxlovid, WHO,
global http://promedmail.org/post/20220705.8704255
COVID-19 update (140): Thailand, human to cat to human transmission
http://promedmail.org/post/20220612.8703819
COVID-19 update (130): surveill., cardiac eff., long COVID subtypes,
WHO, global http://promedmail.org/post/20220601.8703606
COVID-19 update (120): N Korea, pandemic exit, youth vaccine, US
deaths, WHO http://promedmail.org/post/20220518.8703327
COVID-19 update (110): mutations, mental health, China, S Africa,
Paxlovid, WHO http://promedmail.org/post/20220505.8703018
COVID-19 update (100): vacc. intervals, deaths, long COVID,
subvariants, global http://promedmail.org/post/20220420.8702717
COVID-19 update (90): strategy, 2nd booster, WHO
http://promedmail.org/post/20220407.8702454
COVID-19 update (80): animal, USA, deer, transmission
http://promedmail.org/post/20220325.8702212
COVID-19 update (70): case count, UK, BA.2, USA, WHO, global
http://promedmail.org/post/20220312.8701940
COVID-19 update (60): animal, China, origin, research
http://promedmail.org/post/20220227.8701690
COVID-19 update (50): Hong Kong, estrogen risk, maternal vaccine
benefits, WHO http://promedmail.org/post/20220217.8701501
COVID-19 update (40): Denmark, rosemary, pregnancy, stroke, WHO
http://promedmail.org/post/20220205.8701276
COVID-19 update (30): variants in immuno-comp., stability, endemic,
WHO http://promedmail.org/post/20220126.8701074
COVID-19 update (20): Africa vacc., Taiwan, waning immunity,
persistence, global http://promedmail.org/post/20220117.8700915
COVID-19 update (10): animal, omicron origin statement, OIE
http://promedmail.org/post/20220110.8700763
COVID-19 update (01): omicron severity & changes, Germany, T-cell
reactivity http://promedmail.org/post/20220101.8700616]
.................................................pkb/rd/pkb/tw/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DlQsQUvm2e9Z8Rf4E_Hamsz7z7_qav7ud6jKvbnJLyhxoMDAwdTAwMGsLYFJ=
upMva8Uink61k6c6MN7gGYXidfGbAtvZxWuhSJgOlb8VCHehVRUJZKa2CmzEE-oICwNxcGNmhTp=
kWZi5aD-T3UraGNpEJFzh7nPcFTOqO1bicfEe8RU-EoKGLFoq8tJf08mxtrc8QZvMmSsCZTJjkJ=
hGUKOodL_MrjRgaLiHKyzpZ9_EESaTZ5ETfzSVkPHpqHnrGC3cGXR7e6Spu0bbgxVokHe_9a9N3=
EF9qsDQQ8ts7GjN3nPhjw4CppmlWPyWqQghh7EiOqEm1LqOxkusHK2Jb4W7M9qgYqBAK_LeuAjk=
Z9EGlI1SW0-Q6yjB_yNArzBTwQkJYSGVcH1OmT88zSvi1bux-o0O7A-1jJoqNv_SaeYfTeQ5sjp=
8IukYD-jzkrebj2UHToR0uYU419fkqAwk1artcsn5DTUV_j7FxOOrxihk8DqXqUvGKwHuoCxZd1=
kksRCp0AS9-rVRi15aqO_1CInyirJ1RdML1IdZo4F6P01FPY6G3e2dXkzJkTTSjZEA5KEY3L6QH=
FLkW9LkNx3hszrKx_40eu8mvztPZzNEOlalQ9XmSZ_tCpq4KV1KpKH1tWgDOnjST-QveYSDjhc6=
csW5QLek4cPJZCwAUvXkTlFOxYbQkhwfhEcRpQkCX6E3uZMixSERMwkKLGwR6avtanVGo5y8U_Q=
vmJbFyL6Zsn0lRGuCDBcYZsoxarVLBtc7V3dq7eixdB92CsOByugRgGMp3yx_4DOQkqtJhqvFzO=
OIxok8stdYh5QOLAuhMLL4KCjNP_vtu8nD_gAsmgDpNaV1nUWuvMBR6napvED0v68v2xaw9YW1V=
FVfgEEqelQlSojnCPZLJP6l9AwcijeCxqesYH4C1IIsc9hkNM2ilsH9p7Aa_g3Y0bhoxZ7VXrcT=
N7ksNGJxIYB9nPHbYBTDsqsmw9ZIoTLhSItaaP33JA8McTHastqw-TX9BbPcxdPnRIbSsUQF0P8=
8a4jgQNX46aTM5bhzBTy8-LJHNrfbWCCAfgNbCcV8bBqQqZl63DdS2jC5WJzsQy1t_ah8MyB3e8=
C40FEwBUAupwQYCYLVaUyeK7N2Mt1pYrWnACbTEz_s9fFCDenQ9YduGXIJW6TzZsXCC9JyiGcKd=
T1rogw1npmgaNoM46uJeAg6aYYC1oIWoNdE_jhm7QXPhaBKAfUy48buxpmLq2ce0 )
############################################################
############################################################

--04f14b2b4a8967261790b91bbeae5873911717062fdc21b176e90291299e
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>CORONAVIRUS DISEASE 2019 UPDATE (05): PAKISTAN, JN.1, VARIANT OF<br>I=
NTEREST<br>****************************************************************=
*********<br>A ProMED-mail post<br><a href=3D"https://u19268662.ct.sendgrid=
.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3HA/=
42w/WiMrC-CvQ6yAydWsz_eArA/h0/wCaUVO2MZVq9Xh4Le21UaJVAyQhV54mny0NRqI_cVMY">=
http://www.promedmail.org</a><br>ProMED-mail is a program of the<br>Interna=
tional Society for Infectious Diseases<br><a href=3D"https://u19268662.ct.s=
endgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/42w/WiMrC-CvQ6=
yAydWsz_eArA/h1/stxlKAudXuLTMIg0-wXn93h1vgs_PZ5eCXT1jnUqBTQ">http://www.isi=
d.org</a><br><br>Date: Mon 8 Jan 2023 08:05 PKT=0D<br>Source: The Nation [e=
dited]=0D<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_=
iXpbYoMam_aIBhVUNkqc5zEAw8O8s-j2hvfbEInlgbr1xlR_uRLBcwvxBfbPtKQla-Pz7f7q2KU=
CD6cQJ1ujxGdCFJkXi4por9xXCySooRYccplw5Qvi/42w/WiMrC-CvQ6yAydWsz_eArA/h2/7kR=
3xQ2J3ZHfx7-DeH-UJpEPmdCAxmhnA8BBi3y5v7w">https://www.nation.com.pk/08-Jan-=
2024/four-cases-of-jn1-virus-detected-in-pakistan</a>=0D<br>=0D<br>=0D<br>T=
he Ministry of Health's spokesperson has confirmed that 4 cases of<br>the J=
N.1 variant, an omicron sub-variant of the new coronavirus, have<br>been id=
entified in Pakistan. According to the spokesperson, all<br>affected indivi=
duals exhibited mild symptoms, and they have since<br>recovered without com=
plications.=0D<br>=0D<br>The spokesperson added that the World Health Organ=
ization (WHO) has<br>designated JN.1 as a variant of interest. Caretaker Fe=
deral Minister<br>for Health Dr Nadeem Jan emphasized that the government i=
s actively<br>monitoring the situation. Border health services and national=
 and<br>provincial health authorities' labs are on high alert, operating un=
der<br>the health minister's directives to closely track the disease's<br>d=
evelopments.=0D<br>=0D<br>--=0D<br>Communicated by:=0D<br>ProMED=0D<br>via=0D=
<br>ProMED-SoAs<br><br>[As indicated in the news report above, the presence=
 of JN.1<br>sub-variant has been detected in 4 COVID-19 cases in Pakistan. =
With<br>this report, Pakistan has become the 2nd country in South Asia afte=
r<br>India reporting the circulation of this more infectious sub-variant.<b=
r>It would not be surprising to see a temporal increase of COVID-19<br>case=
s in the country due to spread of this sub-variant because of<br>noticing a=
n increasing trend of COVID-19 cases in India suspected to<br>be associated=
 with the circulation of it (see archive nos.<br>http://promedmail.org/post=
/20240103.8714031,<br>http://promedmail.org/post/20231226.8713894 at<br><a =
href=3D"https://u19268662.ct.sendgrid.net/ss/c/0oc7vsq5mmLjPwOs4PjMhy8PNnWO=
X7vm-KABxI_6_SIGGjDAUk_91uRj7G_ai8Eo/42w/WiMrC-CvQ6yAydWsz_eArA/h3/RSLAt9en=
HxXisp_3XFlJhMHj66Zjzt9W2ZkKN_BCf1U">https://promedmail.org/?lang=3Dsoas</a=
>).=0D<br>=0D<br>Of note, "JN.1 is closely related to the variant BA.2.86..=
.. It is not<br>currently known whether JN.1 infection produces different s=
ymptoms<br>from other variants. In general, symptoms of COVID-19 tend to be=
<br>similar across variants. The types of symptoms and how severe they are<=
br>usually depend more on a person's immunity and overall health rather<br>=
than which variant causes the infection." - Mod.PKB=0D<br>(<a href=3D"https=
://u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_iXpbYoMam_PtI61miXazSyoEfBLPy=
ZKA-oy1NYMDc-KHzSzK198WSueDAT_qLmLlfSgJkC7EAP8LWW62Dhe_YYGeJNRyd5RbE379RzhT=
FV3CEVH9ZVg9/42w/WiMrC-CvQ6yAydWsz_eArA/h4/-2geYYKGHtHiFWAtoGF06nWE-DLUyjWt=
ydehvKh3Ovo">https://www.cdc.gov/respiratory-viruses/whats-new/SARS-CoV-2-v=
ariant-JN.1.html</a>)=0D<br>=0D<br>ProMED map of Pakistan:<br><a href=3D"ht=
tps://u19268662.ct.sendgrid.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4Ab=
wuQ3Z6WbkfhqXYXU-aTMPJ8yThkRsYOieSYbBTfno_Xk-tOA/42w/WiMrC-CvQ6yAydWsz_eArA=
/h5/CLeKTgpap9ClVGpHAIvOA95AyiVR5At-EYOgzgmJ2IU">https://promedmail.org/pro=
med-post?place=3D8714143,140</a>]<br><br>[See Also:<br>COVID-19 update (03)=
: Israel, JN.1, new variant<br>http://promedmail.org/post/20240104.8714055=0D=
<br>COVID-19 update (02): India<br>http://promedmail.org/post/20240103.8714=
052=0D<br>COVID-19 update (01): Cambodia, new JN.1 variant detection<br>htt=
p://promedmail.org/post/20240101.8714020=0D<br>2023=0D<br>----=0D<br>COVID-=
19 update (39): Saudi Arabia, JN.1 variant, MOH<br>http://promedmail.org/po=
st/20231222.8713858=0D<br>COVID-19 update (38): WHO classifies JN.1 coronav=
irus strain as<br>'variant of interest' http://promedmail.org/post/20231220=
.8713808=0D<br>COVID-19 update (37): vaccine comp., selected regions, circ.=
 variants,<br>research http://promedmail.org/post/20231219.8713789=0D<br>CO=
VID-19 update (36): selected countries/regions, vaccines<br>http://promedma=
il.org/post/20231212.8713666=0D<br>COVID-19 update (35): Singapore, increas=
e<br>http://promedmail.org/post/20231209.8713618=0D<br>COVID-19 update (34)=
: selected country/region updates, variants, WHO<br>http://promedmail.org/p=
ost/20231130.8713398=0D<br>COVID-19 update (33): country updates, vaccines,=
 vaccine refusal, WHO<br>update http://promedmail.org/post/20231105.8713000=0D=
<br>COVID-19 update (32): updates, variants, vaccines, antivirals,<br>scien=
tific literature http://promedmail.org/post/20231026.8712809=0D<br>COVID-19=
 update (31): BA.2.86 & EG.5, selected regions, vaccines, WHO,<br>global ht=
tp://promedmail.org/post/20231009.8712522=0D<br>COVID-19 update (30): omicr=
on EG.5.1, updates, WHO, global<br>http://promedmail.org/post/20230815.8711=
701=0D<br>COVID-19 update (29): updates, wastewater surveillance, transmiss=
ion,<br>WHO, global http://promedmail.org/post/20230802.8711526=0D<br>COVID=
-19 update (28): superspread, masks, vaccination, WHO, global<br>http://pro=
medmail.org/post/20230724.8711339=0D<br>COVID-19 update (27): vaccination, =
test kit distribution, sequelae,<br>WHO, global http://promedmail.org/post/=
20230717.8711208=0D<br>COVID-19 update (26): animal, North America, wild de=
er as reservoirs<br>http://promedmail.org/post/20230713.8711124=0D<br>COVID=
-19 update (25): vaccines, liver disease, sequelae, WHO, global<br>http://p=
romedmail.org/post/20230713.8711095=0D<br>COVID-19 update (24): long-term e=
ffects, EU.1.1, wild bat, WHO, global<br>http://promedmail.org/post/2023070=
4.8710946=0D<br>COVID-19 update (23): EU transition plan, viral emission, v=
acc<br>hesitancy, GBS, WHO http://promedmail.org/post/20230619.8710662=0D<b=
r>COVID-19 update (22): trends, immunity, children, metformin, WHO<br>http:=
//promedmail.org/post/20230612.8710546=0D<br>COVID-19 update (21): countrie=
s, life expectancy, long COVID,<br>research, WHO, global http://promedmail.=
org/post/20230605.8710423=0D<br>COVID-19 update (20): countries, Paxlovid, =
vaccine, WHO<br>http://promedmail.org/post/20230530.8710317=0D<br>COVID-19 =
update (19): countries, vaccine composition, XBB1.16, WHO,<br>global http:/=
/promedmail.org/post/20230522.8710178=0D<br>COVID-19 update (18): country/r=
egional, vaccine policies, vaccination,<br>WHO, global http://promedmail.or=
g/post/20230516.8710088=0D<br>COVID-19 update (17): WHO, USA, India, China,=
 XBB.1.16, research,<br>global http://promedmail.org/post/20230508.8709926=0D=
<br>COVID-19 update (16): XBB.1.16, reinfections, microglia, sequelae,<br>W=
HO, global http://promedmail.org/post/20230502.8709789=0D<br>COVID-19 updat=
e (15): India, XBB.1.16, fetal brain damage, HCW, global<br>http://promedma=
il.org/post/20230417.8709526=0D<br>COVID-19 update (14): countries, vaccine=
s, XBB.1.16, long COVID, WHO<br>http://promedmail.org/post/20230407.8709377=0D=
<br>COVID-19 update (13): India, surveillance, HCW, rats, infant<br>hospita=
lizations, WHO, global<br>http://promedmail.org/post/20230329.8709196=0D<br=
>COVID-19 update (12): countries, variants, susceptibility, vaccines,<br>WH=
O, global http://promedmail.org/post/20230321.8709066=0D<br>COVID-19 update=
 (11): country responses, complications, treatment,<br>WHO, global http://p=
romedmail.org/post/20230312.8708900=0D<br>COVID-19 update (10): Hong Kong, =
XBB.1.5, Iran, UAE, bivalent vacc<br>http://promedmail.org/post/20230308.87=
08776=0D<br>COVID-19 update (09): XBB.1.5, vaccine, WHO<br>http://promedmai=
l.org/post/20230228.8708641=0D<br>COVID-19 update (08): countries, immunity=
, vaccines, treatment, masks,<br>WHO, global http://promedmail.org/post/202=
30219.8708482=0D<br>COVID-19 update (07): countries, molnupiravir, vaccines=
, PACS,<br>cockroach, WHO http://promedmail.org/post/20230212.8708331=0D<br=
>COVID-19 update (06): China, demographics, symptoms, PACS, WHO<br>http://p=
romedmail.org/post/20230204.8708165=0D<br>COVID-19 update (05): PHEIC conti=
nues, WHO<br>http://promedmail.org/post/20230130.8708059=0D<br>COVID-19 upd=
ate (04): PHEIC, China, susp outbreaks, responses,<br>vaccines, global http=
://promedmail.org/post/20230130.8708043=0D<br>COVID-19 update (03): China, =
guidelines, vacc, immunity, sequelae, WHO<br>http://promedmail.org/post/202=
30122.8707910=0D<br>COVID-19 update (02): China, XBB.1.5, Hong Kong, mAb, p=
athogenesis,<br>WHO, global http://promedmail.org/post/20230115.8707786=0D<=
br>COVID-19 update (01): China, Hong Kong, XBB.1.5, PAHO, treatment,<br>tes=
ting, WHO http://promedmail.org/post/20230107.8707667=0D<br>2022=0D<br>----=0D=
<br>COVID-19 update (193): surge, travel restrictions, screening,<br>treatm=
ent, WHO http://promedmail.org/post/20221230.8707528=0D<br>COVID-19 update =
(191): omicron BF.7, bivalent vaccines, China, WHO,<br>global http://promed=
mail.org/post/20221224.8707437=0D<br>COVID-19 update (190): China, Australi=
a, vaccines, sequelae, WHO,<br>global http://promedmail.org/post/20221219.8=
707306=0D<br>COVID-19 update (189): mortality, mAb, intranasal vacc, NPIs,<=
br>sequelae, WHO, global http://promedmail.org/post/20221209.8707146=0D<br>=
COVID-19 update (188): China, omicron BA.2.76, outdoor transmission<br>http=
://promedmail.org/post/20221130.8706983=0D<br>COVID-19 update (187): booste=
rs, omicron BQ.1.1, Asia, Australia, WHO,<br>global http://promedmail.org/p=
ost/20221129.8706920=0D<br>COVID-19 update (185): chr. COVID, bladder, reco=
very, renal, deaths,<br>WHO, global http://promedmail.org/post/20221111.870=
6665=0D<br>COVID-19 update (184): vaccination response, disparity, WHO, glo=
bal<br>http://promedmail.org/post/20221104.8706549=0D<br>COVID-19 update (1=
83): cardiac events, exercise, US deaths, boosters,<br>WHO, global http://p=
romedmail.org/post/20221028.8706414=0D<br>COVID-19 update (182): frontline =
workers, life expectancy,<br>subvariants, WHO, global http://promedmail.org=
/post/20221021.8706286=0D<br>COVID-19 update (181): Africa vacc hesitancy, =
pre-eclampsia, boosters,<br>nasal vacc, WHO, global http://promedmail.org/p=
ost/20221014.8706143=0D<br>COVID-19 update (180): long COVID, neuropsy. ill=
ness, Paxlovid,<br>subvariants, WHO http://promedmail.org/post/20221007.870=
6007=0D<br>COVID-19 update (170): case severity, boosters, physical activit=
y,<br>WHO, global http://promedmail.org/post/20220825.8705236=0D<br>COVID-1=
9 update (160): vaccine rollout disparities, smell & taste,<br>WHO, global =
http://promedmail.org/post/20220731.8704776=0D<br>COVID-19 update (150): Fr=
ance, omicron 2nd gen variant, paxlovid, WHO,<br>global http://promedmail.o=
rg/post/20220705.8704255=0D<br>COVID-19 update (140): Thailand, human to ca=
t to human transmission<br>http://promedmail.org/post/20220612.8703819=0D<b=
r>COVID-19 update (130): surveill., cardiac eff., long COVID subtypes,<br>W=
HO, global http://promedmail.org/post/20220601.8703606=0D<br>COVID-19 updat=
e (120): N Korea, pandemic exit, youth vaccine, US<br>deaths, WHO http://pr=
omedmail.org/post/20220518.8703327=0D<br>COVID-19 update (110): mutations, =
mental health, China, S Africa,<br>Paxlovid, WHO http://promedmail.org/post=
/20220505.8703018=0D<br>COVID-19 update (100): vacc. intervals, deaths, lon=
g COVID,<br>subvariants, global http://promedmail.org/post/20220420.8702717=0D=
<br>COVID-19 update (90): strategy, 2nd booster, WHO<br>http://promedmail.o=
rg/post/20220407.8702454=0D<br>COVID-19 update (80): animal, USA, deer, tra=
nsmission<br>http://promedmail.org/post/20220325.8702212=0D<br>COVID-19 upd=
ate (70): case count, UK, BA.2, USA, WHO, global<br>http://promedmail.org/p=
ost/20220312.8701940=0D<br>COVID-19 update (60): animal, China, origin, res=
earch<br>http://promedmail.org/post/20220227.8701690=0D<br>COVID-19 update =
(50): Hong Kong, estrogen risk, maternal vaccine<br>benefits, WHO http://pr=
omedmail.org/post/20220217.8701501=0D<br>COVID-19 update (40): Denmark, ros=
emary, pregnancy, stroke, WHO<br>http://promedmail.org/post/20220205.870127=
6=0D<br>COVID-19 update (30): variants in immuno-comp., stability, endemic,=
<br>WHO http://promedmail.org/post/20220126.8701074=0D<br>COVID-19 update (=
20): Africa vacc., Taiwan, waning immunity,<br>persistence, global http://p=
romedmail.org/post/20220117.8700915=0D<br>COVID-19 update (10): animal, omi=
cron origin statement, OIE<br>http://promedmail.org/post/20220110.8700763=0D=
<br>COVID-19 update (01): omicron severity & changes, Germany, T-cell<br>re=
activity http://promedmail.org/post/20220101.8700616]<br>..................=
...............................pkb/rd/pkb/tw/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DlQsQUvm2e9Z8Rf4E_Hamsz7z7_qav7ud6jKvbnJLyhxoMDAwdT=
AwMGsLYFJupMva8Uink61k6c6MN7gGYXidfGbAtvZxWuhSJgOlb8VCHehVRUJZKa2CmzEE-oICw=
NxcGNmhTpkWZi5aD-T3UraGNpEJFzh7nPcFTOqO1bicfEe8RU-EoKGLFoq8tJf08mxtrc8QZvMm=
SsCZTJjkJhGUKOodL_MrjRgaLiHKyzpZ9_EESaTZ5ETfzSVkPHpqHnrGC3cGXR7e6Spu0bbgxVo=
kHe_9a9N3EF9qsDQQ8ts7GjN3nPhjw4CppmlWPyWqQghh7EiOqEm1LqOxkusHK2Jb4W7M9qgYqB=
AK_LeuAjkZ9EGlI1SW0-Q6yjB_yNArzBTwQkJYSGVcH1OmT88zSvi1bux-o0O7A-1jJoqNv_Sae=
YfTeQ5sjp8IukYD-jzkrebj2UHToR0uYU419fkqAwk1artcsn5DTUV_j7FxOOrxihk8DqXqUvGK=
wHuoCxZd1kksRCp0AS9-rVRi15aqO_1CInyirJ1RdML1IdZo4F6P01FPY6G3e2dXkzJkTTSjZEA=
5KEY3L6QHFLkW9LkNx3hszrKx_40eu8mvztPZzNEOlalQ9XmSZ_tCpq4KV1KpKH1tWgDOnjST-Q=
veYSDjhc6csW5QLek4cPJZCwAUvXkTlFOxYbQkhwfhEcRpQkCX6E3uZMixSERMwkKLGwR6avtan=
VGo5y8U_QvmJbFyL6Zsn0lRGuCDBcYZsoxarVLBtc7V3dq7eixdB92CsOByugRgGMp3yx_4DOQk=
qtJhqvFzOOIxok8stdYh5QOLAuhMLL4KCjNP_vtu8nD_gAsmgDpNaV1nUWuvMBR6napvED0v68v=
2xaw9YW1VFVfgEEqelQlSojnCPZLJP6l9AwcijeCxqesYH4C1IIsc9hkNM2ilsH9p7Aa_g3Y0bh=
oxZ7VXrcTN7ksNGJxIYB9nPHbYBTDsqsmw9ZIoTLhSItaaP33JA8McTHastqw-TX9BbPcxdPnRI=
bSsUQF0P88a4jgQNX46aTM5bhzBTy8-LJHNrfbWCCAfgNbCcV8bBqQqZl63DdS2jC5WJzsQy1t_=
ah8MyB3e8C40FEwBUAupwQYCYLVaUyeK7N2Mt1pYrWnACbTEz_s9fFCDenQ9YduGXIJW6TzZsXC=
C9JyiGcKdT1rogw1npmgaNoM46uJeAg6aYYC1oIWoNdE_jhm7QXPhaBKAfUy48buxpmLq2ce0" =
target=3D"_blank" class=3D"Unsubscribe--unsubscribePreferences" style=3D"fo=
nt-family:sans-serif;text-decoration:none;">Unsubscribe Preferences</a></di=
v><br>############################################################<br>#####=
#######################################################<br><br><img src=3D"=
https://u19268662.ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/42w/WiMrC-CvQ=
6yAydWsz_eArA/ho.gif" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=
=3D"height:1px !important;width:1px !important;border-width:0 !important;ma=
rgin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;=
margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !importa=
nt;padding-right:0 !important;padding-left:0 !important;"/></body>
</html>
--04f14b2b4a8967261790b91bbeae5873911717062fdc21b176e90291299e--
